UrbenLMWiedmarJBoettcherEBugs or drugs: are probiotics safe for use in the critically ill?Curr Gastroenterol Rep. 2014;16:388.
2.
WischmeyerPEMcDonaldDKnightR.Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness. Curr Opin Crit Care. 2016;22:347-353.
3.
ZaborinAKrezalekMHyojuSCritical role of microbiota within cecal crypts on the regenerative capacity of the intestinal epithelium following surgical stress. Am J Physiol Gastrointest Liver Physiol. 2017;312:G112-G122.
4.
McDonaldDAckermannGKhailovaLExtreme dysbiosis of the microbiome in critical illness. mSphere. 2016;1:e00199-16.
5.
Food and Agricultural Organization of the United Nations and World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001. http://who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf. Accessed October 2, 2016.
6.
SiemposIINtaidouTKFalagasME.Impact of the administration of probiotics on the incidence of ventilator associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:954-962.
7.
BarraudDBollaertPEGibotS.Impact of the administration of probiotics on mortality in critically ill adult patients. Chest. 2013;143:646-655.
8.
WangJLiuKXArianiFProbiotics for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of high-quality randomized controlled trials. PLoS One. 2013;8:e83934.
9.
GuWJWeiCYYinRX.Lack of efficacy of probiotics in preventing ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. Chest. 2012;142:859-868.
10.
PetrofEODhaliwalRManzanaresWProbiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med. 2012;40:3290-3302.
11.
BoLLiJTaoTProbiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev. 2014;(10):CD009066.
12.
ZengJWangCTZhangFSEffect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Med. 2016;42:1018-1028.
13.
CookDJJohnstoneJMarshalJCProbiotics: prevention of severe pneumonia and endotracheal colonization trial PROSPECT: a pilot trial. Trials. 2016;17:377.
14.
McClaveSATaylorBEMartindaleRGGuidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40:159-211.
15.
Critical Care Nutrition at Clinical Evaluation Research Unit, Kingston General Hospital/Queen’s University. 2015 Canadian Clinical Practice Guidelines. http://criticalcarenutrition.com/docs/CPGs2015/6.22015.pdf. Accessed October 2, 2016.
16.
LhermTMonetCNougiereBSeven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 2002;28:797-801.
17.
Enache-AngooulvantAHennequinC.Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis. 2005;41:1559-1568.
18.
ManzanaresWLemieuxMLangloisPLProbiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care. 2016;20:262.
19.
KoretzRL.Probiotics, critical illness, and methodologic bias. Nutr Clin Pract. 2009;24:45-49.
20.
GoldenbergJZMaSSSaxtonJDProbiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.
21.
HempelSNewberrySJMaherARProbiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307:1959-1969.
22.
LauCSChamberlainRS.Probiotics are effective at preventing Clostridium difficile–associated diarrhea: a systematic review and meta-analysis. Int J Gen Med. 2016;9:27-37.
23.
McFarlandLV.Probiotics for the primary and secondary prevention of Clostridium difficile infections: a meta-analysis and systematic review. Antibiotics. 2015;4:160-178.
24.
SokolHPigneurBWatterlotLFaecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105:16731-16736.
